Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Information

Schedule of segment's loss, including significant segment expenses

	Year Ended December 31,
(In thousands)	2024		2023
Total revenue	$	64,381	$	57,424
Employee-related (Research and development) 1		12,212		12,699
External-related (Research and development)		17,112		14,473
Facilities, depreciation, and other allocated expenses (Research and development)		3,215		5,401
Supporting general and administration functions 1		27,156		31,928
Sales and marketing, and medical affairs 1		25,729		21,202
Share-based compensation		21,393		25,013
Total recurring operating expenses		106,817		110,716
Impairment of long-lived assets		4,513		—
Restructuring and related expenses		—		2,743
Total operating expenses		111,330		113,459
Loss from operations		(46,949)		(56,035)
Interest expense (non-cash)		(2,546)		(2,350)
Interest and other income, net		4,881		9,116
Provision for income tax expense		(11,804)		(5,924)
Net loss	$	(56,418)	$	(55,193)

¹ Excludes share-based compensation